PD04-01: GBP5 upregulation contributes to malignant progression and serves as a potential biomarker for predicting a favorable response to Atezolizumab in clear cell renal cell carcinoma

PD04-02: Efficacy assessment of different treatment strategies in advance/metastatic non-clear cell renal cell carcinoma

PD04-03: The linkage of matrix metalloproteinase 8 genotypes on renal cell carcinoma risks in mid-Taiwan

PD04-04: Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: Simplifying risk assessment with tumor diameter and depth

PD04-05: Robotic partial nephrectomy for renal tumor: The pentafecta outcomes of a single surgeon experience

PD04-06: Use risk factors of International Metastatic RCC Database Consortium (IMDC) to predict the response of cabozatinibin patients with metastatic renal cell carcinoma - a real world analysis